A path to precision in the ICU.

scientific article published on 03 April 2017

A path to precision in the ICU. is ā€¦
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1084251994
P356DOI10.1186/S13054-017-1653-X
P932PMC publication ID5376689
P698PubMed publication ID28366166

P50authorDavid M MasloveQ59764657
P2093author name stringDaren K Heyland
John C Marshall
Francois Lamontagne
P2860cites workA stepwise approach to justify phase III randomized clinical trials and enhance the likelihood of a positive resultQ46767352
Failure to Engage Hospitalized Elderly Patients and Their Families in Advance Care PlanningQ48268983
We should abandon randomized controlled trials in the intensive care unitQ53078056
Individual gene expression and personalised medicine in sepsis.Q54651494
InFACT: a global critical care research response to H1N1Q57237838
Will Precision Medicine Improve Population Health?Q58400951
Genetic and environmental influences on premature death in adult adopteesQ68278175
Personalized medicine, endotypes, and intensive care medicineQ87170357
Precision Medicine for Critical Illness and InjuryQ88130274
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Q26768292
G-DOC Plus - an integrative bioinformatics platform for precision medicine.Q27319225
A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene setQ27325510
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levelsQ28301776
The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedsideQ28744215
MIMIC-III, a freely accessible critical care databaseQ28871995
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFRQ29547545
BioPortal: ontologies and integrated data resources at the click of a mouseQ29617519
Precision medicine in cardiologyQ30249224
Identification of pediatric septic shock subclasses based on genome-wide expression profilingQ30438982
Possible combinations of electronic data capture and randomization systems. principles and the realization with RANDI2 and OpenClinicaQ30754385
Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trialsQ30826105
Fusing Randomized Trials With Big Data: The Key to Self-learning Health Care Systems?Q30989624
Data Resource Profile: the Dutch National Intensive Care Evaluation (NICE) Registry of Admissions to Adult Intensive Care UnitsQ31028868
Genetic influences on incidence and case-fatality of infectious diseaseQ33586137
Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness.Q33744208
Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndromeQ33750995
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?Q33946309
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.Q34057044
Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major traumaQ34147463
Sepsis definitions: time for changeQ34649118
Heart rate variability in critical illness and critical careQ34974165
PCSK9 is a critical regulator of the innate immune response and septic shock outcome.Q35125516
Enrollment into a time sensitive clinical study in the critical care setting: results from computerized septic shock sniffer implementationQ35200305
Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studiesQ35672843
Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray.Q36073104
A Survey of U.S Adults' Opinions about Conduct of a Nationwide Precision Medicine InitiativeĀ® Cohort Study of Genes and EnvironmentQ36105829
Phenotypic clusters within sepsis-associated multiple organ dysfunction syndromeQ36166232
Continuous enteral and parenteral feeding each reduces heart rate variability but differentially influences monocyte gene expression in humans.Q36191129
Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical CareQ36272381
Development and implementation of a high-quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient DatabaseQ36504261
The microbiome and critical illnessQ36575777
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort studyQ36764754
Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patientsQ36838630
Could Biomarkers Direct Therapy for the Septic Patient?Q36852546
Toward precision medicine and health: Opportunities and challenges in allergic diseasesQ36916201
Association of common genetic variation in the protein C pathway genes with clinical outcomes in acute respiratory distress syndromeQ36925835
Identification of sepsis subtypes in critically ill adults using gene expression profilingQ36928191
Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial DesignQ37213606
Metabolomic derangements are associated with mortality in critically ill adult patientsQ37534631
The Clinical Utility of Precision Medicine: Properly Assessing the Value of Emerging Diagnostic TestsQ37809964
Sniffing out acute kidney injury in the ICU: do we have the tools?Q38154109
The beginning of personalized medicine in sepsis: small steps to a bright futureQ38191987
Personalized medicine for ARDS: the 2035 research agendaQ38381656
Brain Tissue Oxygenation in Patients with Septic Shock: a Feasibility StudyQ38387057
Sepsis: a roadmap for future researchQ38453261
The Evolving Landscape of HER2 Targeting in Breast CancerQ38552750
Precision respiratory medicine and the microbiomeQ38678093
Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision MedicineQ38862332
Why have clinical trials in sepsis failed?Q39242451
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile ChildrenQ39462634
Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.Q39499760
Errors, Omissions, and Outliers in Hourly Vital Signs Measurements in Intensive CareQ39504006
Genomics and pharmacogenomics of sepsis: so close and yet so far.Q40623421
Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids.Q40642645
Predicting Performance Status 1 Year After Critical Illness in Patients 80 Years or Older: Development of a Multivariable Clinical Prediction ModelQ40802479
Mortality in Multicenter Critical Care Trials: An Analysis of Interventions With a Significant Effect.Q41141860
Septic shock in the era of precision medicineQ41837623
"Big data" in the intensive care unit. Closing the data loopQ42539340
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsisQ44273818
Personalized medicine: genetic variation and loss of physiologic complexity are associated with mortality in 644 trauma patientsQ44540725
The randomized registry trial--the next disruptive technology in clinical research?Q44663056
Thrombus aspiration during ST-segment elevation myocardial infarctionQ44802449
It's all in the genes: moving toward precision medicine in critical illnessQ45333854
The platform trial: an efficient strategy for evaluating multiple treatments.Q45982371
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectprecision medicineQ17075943
P304page(s)79
P577publication date2017-04-03
P1433published inCritical CareQ5186602
P1476titleA path to precision in the ICU.
P478volume21

Reverse relations

cites work (P2860)
Q64901793Critical Care, Critical Data.
Q97530127Generalizable deep temporal models for predicting episodes of sudden hypotension in critically ill patients: a personalized approach
Q92006074Impact of blood group on survival following critical illness: a single-centre retrospective observational study
Q57067267Machine learning for real-time prediction of complications in critical care: a retrospective study
Q61778761Paths into Sepsis: Trajectories of Presepsis Healthcare Use
Q57158814Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids
Q42346459Point-of-care ultrasonography: a practical step in the path to precision in critical care
Q92736905Precision Medicine and its Role in the Treatment of Sepsis: A Personalised View
Q59794487Predicting Patient-ventilator Asynchronies with Hidden Markov Models
Q90614358Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays
Q42337552Systematic assessment of advanced respiratory physiology: precision medicine entering real-life ICU?
Q47750410Therapeutic bronchoscopy vs. standard of care in acute respiratory failure: a systematic review
Q47111588Time-sensitive therapeutics
Q55341179Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study.

Search more.